Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M Najarro is active.

Publication


Featured researches published by M Najarro.


International Journal of Pharmaceutics | 2002

Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin.

Daniela Monti; Patrizia Chetoni; Susi Burgalassi; M Najarro; M.Fabrizio Saettone; Enrico Boldrini

Purpose of the present investigation was to evaluate six terpene-containing essential oils for their capacity to promote permeation of estradiol (ES) through hairless mouse skin in vitro. Tests on cajuput, cardamom, melissa, myrtle, niaouli and orange oil, all used at the 10% w/w concentration in propylene glycol (PG), evidenced niaouli oil (NIA) as the best permeation promoter for ES. Tests on the main terpene components of NIA (1,8 cineole, alpha-pinene, alpha-terpineol and D-limonene), evaluated neat (10% w/w in PG) or in admixture, confirmed the better promoting activity of whole NIA. The present data point to the validity of complex terpene mixtures, such as that composing NIA, as transdermal penetration enhancers for moderately lipophilic drugs like ES.


Journal of Drug Delivery Science and Technology | 2007

Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity

Patrizia Chetoni; Susi Burgalassi; Daniela Monti; M Najarro; Enrico Boldrini

Mitomycin-C (MMC), a potent antibiotic-antineoplastic drug, has recently proven to be useful as additional treatment in ocular surgery (pterygium, glaucoma filtering, photorefractive laser keratectomy, etc.) when inhibiting the epithelial wound healing response and reducing surgical scarring is beneficial to surgical success. However, the therapeutic benefits of MMC are frequently offset by ocular toxicity and undesirable side effects (retinal toxicity, corneal edema, corneal perforation, cataract, secondary glaucoma, iritis, scleral calcification, pain, etc.). The purpose of this study was to evaluate if a liposomal preparation containing MMC was capable of reducing the corneal healing rate and drug toxicity of a corneal lesion in a rabbit model. To do this, a liposomal formulation containing 0.2 mg/ml of MMC was prepared and tested against aqueous solutions and viscous formulations based on tamarind seeds polysaccharide (TSP), which were used as references. In vitro release of MMC from the vehicles through a dialysis membrane was characterized by a fast diffusion of MMC from the aqueous solution, while a more gradual release from the TSP and the liposomal formulations was observed. To evaluate the intraocular penetration of MMC, the drug amount in the aqueous and vitreous humor of the animals was determined 60 min after treatment. MMC toxicity was analyzed by monitoring the proliferation and viability of a rabbit corneal epithelial cell line (RCE) in the different formulations under study. These results showed reduced cytotoxicity for MMC in TSP viscous vehicles; however, only the liposomal MMC vehicle appeared to produce both lower toxicity for a rabbit corneal epithelial cell line (RCE) culture and a substantial reduction of the corneal healing rate in vivo.


International Journal of Pharmaceutics | 2002

Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation

Daniela Monti; Patrizia Chetoni; Susi Burgalassi; M Najarro; Mf Saettone


Journal of Drug Delivery Science and Technology | 2005

Vehicle and enhancer effects on transdermal permeation of estradiol from gel formulations: evaluation in vitro

Daniela Monti; M Najarro; Patrizia Chetoni; Susi Burgalassi; Mf Saettone; Enrico Boldrini


Journal of Drug Delivery Science and Technology | 2006

Niaouli oil as enhancer for transdermal permeation of estradiol Evaluation of gel formulations on hairless rats in vivo

Daniela Monti; M Najarro; Patrizia Chetoni; Susi Burgalassi; Mf Saettone; Enrico Boldrini


XX Simposio ADRITELF “La tecnologia farmaceutica nell’università e nell’industria”, Catania, 4-7 Ottobre 2006 | 2006

Liposome-encapsulated mitomycin-C for reduction of corneal healing rate and ocular toxicity.

M Najarro; Patrizia Chetoni; Susi Burgalassi; Daniela Monti; Enrico Boldrini


NCF. NOTIZIARIO CHIMICO E FARMACEUTICO | 2006

Aloe purificata: formulazioni oftalmiche

C Sommani; Susi Burgalassi; Daniela Monti; M Najarro; Patrizia Chetoni


6th International Symposium on Ocular Pharmacology and Therapeutics, ISOPT, Berlino, 30 marzo-2 aprile 2006 | 2006

Cytotoxicity on rabbit corneal epithelial cell cultures of some polymers used as ophthalmic adjuvants

Patrizia Chetoni; Daniela Monti; M Najarro; Susi Burgalassi


European Conference on Drug Delivery and Pharmaceutical Technology. Seville, Spain May 2004 | 2004

Liposome-encapsulated triamcinolone acetonide: in vitro/in vivo evaluation

Daniela Monti; Patrizia Chetoni; Susi Burgalassi; T Tognetti; M Najarro; Enrico Boldrini; Mf Saettone


The XXXV Nordic Congress of Ophthalmology, Tampere, Finland, 23-27 August 2002 | 2002

Evaluation in rabbits of a liposomal formulation for ocular delivery of acyclovir

M Najarro; Patrizia Chetoni; Susi Burgalassi; Daniela Monti; Stefano Mariotti; Mf Saettone

Collaboration


Dive into the M Najarro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge